» Articles » PMID: 32531935

Chronic Inflammation in the Context of Everyday Life: Dietary Changes As Mitigating Factors

Overview
Publisher MDPI
Date 2020 Jun 14
PMID 32531935
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The lifestyle adopted by most people in Western societies has an important impact on the propensity to metabolic disorders (e.g., diabetes, cancer, cardiovascular disease, neurodegenerative diseases). This is often accompanied by chronic low-grade inflammation, driven by the activation of various molecular pathways such as STAT3 (signal transducer and activator of transcription 3), IKK (IκB kinase), MMP9 (matrix metallopeptidase 9), MAPK (mitogen-activated protein kinases), COX2 (cyclooxigenase 2), and NF-Kβ (nuclear factor kappa-light-chain-enhancer of activated B cells). Multiple intervention studies have demonstrated that lifestyle changes can lead to reduced inflammation and improved health. This can be linked to the concept of real-life risk simulation, since humans are continuously exposed to dietary factors in small doses and complex combinations (e.g., polyphenols, fibers, polyunsaturated fatty acids, etc.). Inflammation biomarkers improve in patients who consume a certain amount of fiber per day; some even losing weight. Fasting in combination with calorie restriction modulates molecular mechanisms such as m-TOR, FOXO, NRF2, AMPK, and sirtuins, ultimately leads to significantly reduced inflammatory marker levels, as well as improved metabolic markers. Moving toward healthier dietary habits at the individual level and in publicly-funded institutions, such as schools or hospitals, could help improving public health, reducing healthcare costs and improving community resilience to epidemics (such as COVID-19), which predominantly affects individuals with metabolic diseases.

Citing Articles

The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation.

Yu W, Sun S, Fu Q Front Immunol. 2025; 16:1519925.

PMID: 39991152 PMC: 11842938. DOI: 10.3389/fimmu.2025.1519925.


Vitamin D and COVID-19: comparative analysis with other respiratory infections and impact of comorbidities.

Constantin L, Ungurianu A, Tarcomnicu I, Balulescu E, Margina D Germs. 2025; 14(3):232-245.

PMID: 39776957 PMC: 11703589. DOI: 10.18683/germs.2024.1435.


Impacts of supplementation with milk proteins on inflammation: a systematic review and meta-analysis.

Mohammadi S, Ashtary-Larky D, Mehrbod M, Kouhi Sough N, Omran H, Dolatshahi S Inflammopharmacology. 2025; .

PMID: 39775243 DOI: 10.1007/s10787-024-01615-8.


Microbiota in the ptarmigan intestine-An Inuit delicacy and its potential in popular cuisine.

Bjornsen M, Valeron N, Vasquez D, Velasco E, Hansen A, Hauptmann A PLoS One. 2024; 19(12):e0305317.

PMID: 39715180 PMC: 11666028. DOI: 10.1371/journal.pone.0305317.


Soluble P-selectin as an inflammatory mediator potentially influencing endothelial activation in people living with HIV in sub-rural areas of Limpopo, South Africa.

Mokoena H, Mabhida S, Choshi J, Sekgala M, Nkambule B, Ndwandwe D PLoS One. 2024; 19(11):e0310056.

PMID: 39602436 PMC: 11602056. DOI: 10.1371/journal.pone.0310056.


References
1.
Kenyon C . The genetics of ageing. Nature. 2010; 464(7288):504-12. DOI: 10.1038/nature08980. View

2.
De Lorenzo A, Soldati L, Sarlo F, Calvani M, Lorenzo N, Di Renzo L . New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol. 2016; 22(2):681-703. PMC: 4716069. DOI: 10.3748/wjg.v22.i2.681. View

3.
Statovci D, Aguilera M, MacSharry J, Melgar S . The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces. Front Immunol. 2017; 8:838. PMC: 5532387. DOI: 10.3389/fimmu.2017.00838. View

4.
Power S, OToole P, Stanton C, Ross R, Fitzgerald G . Intestinal microbiota, diet and health. Br J Nutr. 2013; 111(3):387-402. DOI: 10.1017/S0007114513002560. View

5.
Halagappa V, Guo Z, Pearson M, Matsuoka Y, Cutler R, LaFerla F . Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis. 2007; 26(1):212-20. DOI: 10.1016/j.nbd.2006.12.019. View